阿仑膦酸钠与激素替代疗法治疗骨质疏松症的比较

发布时间：2018-05-18 20:55

本文选题：阿仑膦酸钠 + 激素替代疗法　；参考：《健康之路》2018年01期

【摘要】：目的:探讨分析阿仑膦酸钠与激素替代疗法治疗骨质疏松症的临床治疗效果。方法:随机的选取我院2015年10月至2016年12月之间接受治疗的100例骨质疏松症患者,随机地将其分为观察组和对照组两组,平均每组为50例。对照组的骨质疏松症患者口服替勃龙片,观察组的骨质疏松症患者口服阿仑膦酸钠。两组患者都连续服用一年。最后,将两组之间的不良反应发生状况以及临床治疗效果进行比较。结果:观察组的总有效率为94.00%,对照组的总有效率为62.00%,观察组的总有效率明显高于对照组。观察组的不良反应发生状况好于对照组。(P0.05),表示为两组之间的差异具有统计学意义。结论:与激素替代疗法相比较,阿仑膦酸钠在治疗骨质疏松症方面,具有十分良好的临床治疗效果。它能够有效的降低骨质疏松症患者不良反应发生率,有效的缓解患者的病情。
[Abstract]:Objective: to investigate the clinical effect of alendronate and hormone replacement therapy in the treatment of osteoporosis. Methods: 100 patients with osteoporosis received treatment from October 2015 to December 2016 were randomly divided into two groups: observation group and control group, with an average of 50 cases in each group. Osteoporosis patients in the control group were given tibolone tablets and those in the observation group were treated with alendronate. Both groups were given for one year. Finally, the incidence of adverse reactions and clinical efficacy were compared between the two groups. Results: the total effective rate of the observation group was 94.00 and the total effective rate of the control group was 62.00. The total effective rate of the observation group was significantly higher than that of the control group. The incidence of adverse reactions in the observation group was better than that in the control group, indicating that the difference between the two groups was statistically significant. Conclusion: compared with hormone replacement therapy, alendronate has a good clinical effect in the treatment of osteoporosis. It can effectively reduce the incidence of adverse reactions in patients with osteoporosis, and effectively alleviate the condition of patients.
【作者单位】：冀中能源邢台矿业集团有限责任公司总医院;
【分类号】：R580

【相似文献】